Bayer Aktiengesellschaft
BAY.WA · WSE
Bulios Fair Price
131.1 zł
40.3% downside
Current Price
219.6 zł
According to Bulios Fair Price, BAY.WA is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Bayer Aktiengesellschaft (BAYN) is a global pharmaceutical and chemical company headquartered in Germany. Bayer focuses on research, development, and manufacturing of pharmaceuticals, agrochemicals, and consumer products. Their portfolio includes medicines for treating various diseases, including cardiovascular diseases, neurological disorders, cancer, among others. Additionally, Bayer produces and distributes a wide range of agrochemical products for plant protection and crop care. The company is also known for its consumer products, such as over-the-counter medications, personal care, household, and veterinary products. Bayer invests in research and development of new drugs, agrochemicals, and innovative technologies to continuously innovate its portfolio and provide effective and safe products to its customers. Bayer Aktiengesellschaft (BAYN) shares are considered an attractive investment for investors seeking a stable and diversified investment in the pharmaceutical and chemical industries with an emphasis on innovation and quality.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Bill Anderson
Employees
88,078
Headquarters
Leverkusen
Upcoming events
Earnings
Upcoming earnings report